The International Agency for Research on Cancer forecasts over 35 million new cancer cases in 2050 globally. The growing ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

The Columbia Basin Cancer Foundation finally has some breathing room. "We were really shoved into a little box," said Community Relations Coordinator Amanda Carpenter. "We made it work, and it was ...

The right of transgender minors to access gender-affirming care has sparked debate in many parts of the United States, and it ...

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

The Supreme Court, in a 6-3 decision, upheld a Tennessee law banning minors from receiving transgender medical treatments.

Seoul St. Mary's Hospital, which established the first blood hospital in Korea, revealed the results of the treatment of ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid  Approval based on pivotal results showing improvements in sustained disease remission and ...

Jurisdictions in Spokane County will receive nearly $4.7 million as part of a multibillion-dollar settlement with Purdue ...

The FDA is staffed with medical experts who have the capability to evaluate insurance algorithms before they are used to make coverage decisions. The agency already reviews many medical AI tools for ...

The court's decision in the landmark U.S. v. Skrmetti case is expected to upend access to healthcare for trans youth.

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for chemotherapy in certain patients with NSCLC.